BETHEL, Conn.,Jan. 26 /PRNewswire-FirstCall/ -- MedClean Technologies, Inc., a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste, today announced that it has received notification from The NASDAQ Stock Market LLC(R) that NASDAQ has received the necessary documentation to process their request for a name change from Aduromed Industries, Inc. to MedClean Technologies, Inc. The Company will begin trading under the new stock symbol, "MCLN," on the OTC Bulletin Board at the open of business on January 26, 2009.
Advertisement
This action was commenced as part of the Company's rebranding initiative launched January 2, 2009 to capture leadership in the $2 billion market opportunity for regulated medical waste treatment solutions.
Advertisement
About MedClean Technologies, Inc.
MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean(R) Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at http://www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at http://www.sec.gov.
Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business, including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2007, filed with the SEC on March 31, 2008, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.
Contacts: MedClean Technologies, Inc. Kevin Dunphy Chief Financial Officer (203) 798-1080 [email protected] Investor Contact: Cameron Donahue Hayden IR (651) 653-1854 [email protected]
SOURCE MedClean Technologies, Inc.
